AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25335251 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive therapy group (electroacupuncture at qi streets acupoints combined with spinal regulation method)
Number of subjects: 60
Study 25335251 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive therapy group
Number of subjects: 60
Study 25335251 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive therapy group and medication group
Number of subjects: 60
Study 23910646 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg/day with peginterferon alfa plus ribavirin
Number of subjects: 37
Study 23910646 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alfa plus ribavirin (Control)
Number of subjects: 37
Study 23910646 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin users (not randomized) with peginterferon/ribavirin
Number of subjects: 37
Study 20675955 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/day pitavastatin
Number of subjects: 251
Study 20675955 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day atorvastatin
Number of subjects: 251
Study 20675955 — intervention group
Group type: COMPARATOR
Intervention: Lower HDL-cholesterol levels
Number of subjects: 251
Study 18947913 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition (fining minors for possessing or using tobacco)
Number of subjects: 25404
Study 18947913 — intervention group
Group type: COMPARATOR
Intervention: Control condition (reducing commercial sources of youth access to tobacco)
Number of subjects: 25404
Study 17060212 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted hygiene programme including educational activities and environmental changes
Number of subjects: 0
Study 17060212 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the hygiene programme after the study
Number of subjects: 0
Study 12788962 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting β2-agonists (salmeterol or formoterol) used as second-line treatment for 1 week or more
Number of subjects: 596
Study 12788962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 596
Study 11105182 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 104
Study 11105182 — intervention group
Group type: COMPARATOR
Intervention: Minimal needling
Number of subjects: 104
Study 11105182 — intervention group
Group type: COMPARATOR
Intervention: Antiemetic pharmacotherapy alone
Number of subjects: 104
Study 8731623 — intervention group
Group type: EXPERIMENTAL
Intervention: General practice education/advice
Number of subjects: 130
Study 8731623 — intervention group
Group type: COMPARATOR
Intervention: Hospital treatment and education/advice
Number of subjects: 130
Study 1574950 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10‐40 mg/day
Number of subjects: 10
Study 3889261 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 90
Study 3889261 — intervention group
Group type: COMPARATOR
Intervention: amoxicillin
Number of subjects: 90
Study 31676258 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 145
Study 31676258 — intervention group
Group type: COMPARATOR
Intervention: TRAD group
Number of subjects: 145
Study 30870279 — intervention group
Group type: EXPERIMENTAL
Intervention: Midurethral sling placement during surgery
Number of subjects: 152
Study 30870279 — intervention group
Group type: COMPARATOR
Intervention: No midurethral sling placement during surgery
Number of subjects: 152
Study 30870279 — intervention group
Group type: EXPERIMENTAL
Intervention: Model including preoperative stress test
Number of subjects: 152
Study 28870887 — intervention group
Group type: COMPARATOR
Intervention: REST
Number of subjects: 12
Study 28870887 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-min
Number of subjects: 12
Study 28870887 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min
Number of subjects: 12
Study 28870887 — intervention group
Group type: EXPERIMENTAL
Intervention: 45-min
Number of subjects: 12
Study 28870887 — intervention group
Group type: EXPERIMENTAL
Intervention: All exercise trials
Number of subjects: 12
Study 26401946 — intervention group
Group type: EXPERIMENTAL
Intervention: Macular pigment (MP) measurement
Number of subjects: 226
Study 26401946 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum lutein (L) concentrations
Number of subjects: 226
Study 26401946 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum zeaxanthin (Z) concentrations
Number of subjects: 226
Study 23273405 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol 250/10 μg b.i.d.
Number of subjects: 395
Study 22248464 — intervention group
Group type: EXPERIMENTAL
Intervention: Photogrammetric method for assessing body posture
Number of subjects: 563
Study 19278300 — intervention group
Group type: EXPERIMENTAL
Intervention: 375 μg interferon-β-1b
Number of subjects: 145
Study 19278300 — intervention group
Group type: COMPARATOR
Intervention: 250 μg interferon-β-1b
Number of subjects: 145
Study 16441324 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor:student ratio of 6:12
Number of subjects: 108
Study 16441324 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor:student ratio of 3:12
Number of subjects: 108
Study 16441324 — intervention group
Group type: COMPARATOR
Intervention: Instructor:student ratio of 1:12
Number of subjects: 108
Study 15292625 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychotherapy or social support group (intervention program)
Number of subjects: 69
Study 15292625 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support group (intervention program)
Number of subjects: 69
Study 15292625 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 69
Study 11691573 — intervention group
Group type: EXPERIMENTAL
Intervention: Isepamicin at 7.5 mg/kg i.v. q 12 h
Number of subjects: 39
Study 11691573 — intervention group
Group type: COMPARATOR
Intervention: Amikacin at 7.5 mg/kg i.v. q 12 h
Number of subjects: 39
Study 9116986 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance directive education
Number of subjects: 0
Study 9116986 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 8131769 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril, 25 mg three times daily
Number of subjects: 78
Study 8131769 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 78
Study 3312530 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 0
Study 3312530 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 3312530 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment groups
Number of subjects: 0
Study 3312530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29037093 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterolateral approach
Number of subjects: 51
Study 29037093 — intervention group
Group type: COMPARATOR
Intervention: Direct lateral approach
Number of subjects: 51
Study 27912871 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile extract 1500mg/day for up to 8 weeks
Number of subjects: 179
Study 24711481 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate-responsive single chamber pacing (n=707)
Number of subjects: 1415
Study 24711481 — intervention group
Group type: COMPARATOR
Intervention: Rate-responsive dual chamber pacing (n=708)
Number of subjects: 1415
Study 24711481 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1415
Study 24711481 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who experienced syncope post pacemaker implant
Number of subjects: 1415
Study 23078636 — intervention group
Group type: EXPERIMENTAL
Intervention: Temptation to drink (self-reported measure)
Number of subjects: 0
Study 23078636 — intervention group
Group type: EXPERIMENTAL
Intervention: Temptation to drink (self-reported measure during the fourth session of treatment)
Number of subjects: 0
Study 23078636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichotomous measure of temptation to drink (not at all tempted vs. all other levels)
Number of subjects: 0
Study 20948590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue Base Reduction with Thyro-Hyoido-Pexy (TBRTHP)
Number of subjects: 12
Study 20948590 — intervention group
Group type: COMPARATOR
Intervention: Tongue Base Reduction with Hyo-Epiglottoplasty (TBRHE)
Number of subjects: 12
Study 18373146 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 161
Study 18373146 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention
Number of subjects: 161
Study 18373146 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet intervention
Number of subjects: 161
Study 18373146 — intervention group
Group type: COMPARATOR
Intervention: All interventions (video, internet, pamphlet)
Number of subjects: 161
Study 16617645 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:400,000 adrenaline
Number of subjects: 40
Study 16617645 — intervention group
Group type: COMPARATOR
Intervention: Normal saline with 1:400,000 adrenaline
Number of subjects: 40
Study 14599997 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiredness in daily activities (measured by questionnaire surveys)
Number of subjects: 1396
Study 14599997 — intervention group
Group type: EXPERIMENTAL
Intervention: Low social participation, poor psychological function, and physical inactivity (risk factors identified)
Number of subjects: 1396
Study 14599997 — intervention group
Group type: EXPERIMENTAL
Intervention: Home help, low sense of coherence, and physical inactivity (risk factors identified)
Number of subjects: 1396
Study 11072443 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa (25 mg carbidopa and 100 mg levodopa, one tablet TID for 1 week, 1 1/2 tablets TID for 1 week, then two tablets TID for 6 weeks)
Number of subjects: 40
Study 11072443 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa
Number of subjects: 40
Study 11072443 — intervention group
Group type: COMPARATOR
Intervention: Placebo (from a previously reported bupropion smoking cessation trial)
Number of subjects: 40
Study 11072443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11072443 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa and Placebo
Number of subjects: 40
Study 8773860 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg.kg-1 ketorolac i.v.
Number of subjects: 64
Study 8773860 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mg.kg-1 codeine im
Number of subjects: 64
Study 1335644 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine lot 1
Number of subjects: 204
Study 1335644 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine lot 2
Number of subjects: 204
Study 1335644 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine lot 3
Number of subjects: 204
Study 1335644 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine lots 1, 2, and 3
Number of subjects: 204
Study 6138083 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg midazolam
Number of subjects: 6
Study 6138083 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg triazolam
Number of subjects: 6
Study 6138083 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mg alpha-hydroxy midazolam
Number of subjects: 6
Study 6138083 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg alpha-hydroxy triazolam
Number of subjects: 6
Study 6138083 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg 4-hydroxy triazolam
Number of subjects: 6
Study 6138083 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 6
Study 31831044 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-learning training on the SOP and checklist (group B)
Number of subjects: 80
Study 31831044 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive discussion panel regarding the SOP and checklist (group C)
Number of subjects: 80
Study 31831044 — intervention group
Group type: COMPARATOR
Intervention: Self-learning course with textbooks (group A)
Number of subjects: 80
Study 31831044 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 80
Study 31831044 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B and C acceptance questionnaire score
Number of subjects: 80
Study 30267162 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored letter containing DXA results and educational osteoporosis brochure
Number of subjects: 7749
Study 30267162 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 7749
Study 26674653 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (capillary oxygen saturation 70-75%)
Number of subjects: 15
Study 26674653 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 15
Study 24161482 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 healthy women matched for age and body mass index)
Number of subjects: 22
Study 24161482 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CSX
Number of subjects: 22
Study 18218055 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic occlusion
Number of subjects: 18
Study 18218055 — intervention group
Group type: COMPARATOR
Intervention: Lingualized occlusion
Number of subjects: 18
Study 15191774 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularisation (PCI or CABG surgery)
Number of subjects: 301
Study 15191774 — intervention group
Group type: COMPARATOR
Intervention: Surgical patients (CABG)
Number of subjects: 301
Study 11279797 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous tumor cell vaccines (10 million irradiated tumor cells with various adjuvants, weekly x3 and then monthly x5)
Number of subjects: 69
Study 11279797 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous tumor cell vaccines
Number of subjects: 69
Study 9644824 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent articulation during the serial report task
Number of subjects: 0
Study 9644824 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent tapping during the serial report task
Number of subjects: 0
Study 9644824 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-alternative forced choice tests for memory of pattern configuration
Number of subjects: 0
Study 9644824 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial report task
Number of subjects: 0
Study 9644824 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-choice item recognition task
Number of subjects: 0
Study 7943302 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (77% VO2max)
Number of subjects: 10
Study 7943302 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (62% VO2max)
Number of subjects: 10
Study 7943302 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity/Low-intensity exercise (HI/LI)
Number of subjects: 10
Study 7943302 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity/High-intensity exercise (LI/HI)
Number of subjects: 10
Study 3062604 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamterene-containing preparation
Number of subjects: 80
Study 3062604 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 80
Study 3062604 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 80
Study 3062604 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 11684372 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 50 microg/die for 12 cycles
Number of subjects: 50
Study 11684372 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches for 12 cycles
Number of subjects: 50
Study 30912708 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-disclosure (factual, cognitive, emotional) with similarity
Number of subjects: 280
Study 30912708 — intervention group
Group type: COMPARATOR
Intervention: Self-disclosure (factual, cognitive, emotional) with dissimilarity
Number of subjects: 280
Study 30199562 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-guided PRK
Number of subjects: 215
Study 30199562 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-optimized PRK
Number of subjects: 215
Study 30199562 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-guided LASIK
Number of subjects: 215
Study 30199562 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-optimized LASIK
Number of subjects: 215
Study 30199562 — intervention group
Group type: COMPARATOR
Intervention: All groups (PRK and LASIK)
Number of subjects: 215
Study 27413741 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow sevoflurane anesthesia (1 L/min)
Number of subjects: 60
Study 27413741 — intervention group
Group type: COMPARATOR
Intervention: High-flow sevoflurane anesthesia (4 L/min)
Number of subjects: 60
Study 25039401 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarter turn from prone
Number of subjects: 54
Study 25039401 — intervention group
Group type: COMPARATOR
Intervention: Supine
Number of subjects: 54
Study 25039401 — intervention group
Group type: COMPARATOR
Intervention: Prone
Number of subjects: 54
Study 23268736 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral vitamin D3 dose (70,000 IU)
Number of subjects: 61
Study 19887137 — intervention group
Group type: EXPERIMENTAL
Intervention: ACWY-TT conjugate vaccine
Number of subjects: 508
Study 17636154 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance exercise group (n=17)
Number of subjects: 36
Study 17636154 — intervention group
Group type: COMPARATOR
Intervention: Falls prevention education group (n=19)
Number of subjects: 36
Study 16045141 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous ketamine (0.15 mg kg(‐1))
Number of subjects: 90
Study 16045141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl (10 microg)
Number of subjects: 90
Study 16045141 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal saline)
Number of subjects: 90
Study 16045141 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous ketamine
Number of subjects: 90
Study 12394893 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment (Group A)
Number of subjects: 68
Study 12394893 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (Group B)
Number of subjects: 68
Study 12394893 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed 10-m walk test (Group A)
Number of subjects: 68
Study 10363198 — intervention group
Group type: COMPARATOR
Intervention: Double therapy (interferon alpha + oral ribavirin)
Number of subjects: 20
Study 10363198 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (interferon alpha + oral ribavirin + oral amantadine)
Number of subjects: 20
Study 8881849 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal oestrogen patch releasing 50 micrograms oestradiol 24 h-1
Number of subjects: 16
Study 8881849 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 16
Study 2047182 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nucleinate
Number of subjects: 0
Study 2047182 — intervention group
Group type: EXPERIMENTAL
Intervention: Diucifon
Number of subjects: 0
Study 2047182 — intervention group
Group type: COMPARATOR
Intervention: Placebo (calcium gluconate)
Number of subjects: 0
Study 6258237 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 0
Study 6258237 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 0
Study 30107449 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron therapy
Number of subjects: 50
Study 30107449 — intervention group
Group type: COMPARATOR
Intervention: Oral iron therapy
Number of subjects: 50
Study 28277403 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 15
Study 28277403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 26648450 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical coenzyme Q10-containing formulas
Number of subjects: 0
Study 25018624 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Radial Approach (LRA)
Number of subjects: 1400
Study 25018624 — intervention group
Group type: COMPARATOR
Intervention: Right Radial Approach (RRA)
Number of subjects: 1400
Study 23053780 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-piece IOL
Number of subjects: 40
Study 23053780 — intervention group
Group type: COMPARATOR
Intervention: Three-piece IOL
Number of subjects: 40
Study 23053780 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ACD
Number of subjects: 40
Study 23053780 — intervention group
Group type: COMPARATOR
Intervention: Comparison of iris-to-IOL distance
Number of subjects: 40
Study 19715381 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal soluble film (FBSF) pH 6
Number of subjects: 12
Study 19715381 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal soluble film (FBSF) pH 7.25
Number of subjects: 12
Study 19715381 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal soluble film (FBSF) pH 8.5
Number of subjects: 12
Study 19715381 — intervention group
Group type: COMPARATOR
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 12
Study 17890356 — intervention group
Group type: COMPARATOR
Intervention: Fixed contrast material dose (120 mL of iohexol 300) at an injection rate of 4.0 mL/sec (Protocol 1)
Number of subjects: 78
Study 17890356 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose tailored to patient's body weight (2.0 mL/kg) injected over 30 seconds (Protocol 2)
Number of subjects: 78
Study 14999221 — intervention group
Group type: EXPERIMENTAL
Intervention: PT-141 (4 mg)
Number of subjects: 0
Study 14999221 — intervention group
Group type: EXPERIMENTAL
Intervention: PT-141 (6 mg)
Number of subjects: 0
Study 14999221 — intervention group
Group type: EXPERIMENTAL
Intervention: PT-141 (0.3 to 10 mg)
Number of subjects: 0
Study 14999221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11146577 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) with transdermal estrogen with or without progestogen
Number of subjects: 64
Study 11146577 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy pre-menopausal and post-menopausal women)
Number of subjects: 64